University of Wisconsin, Madison: Lymphoma trials

The registry lists 15 Lymphoma studies with University of Wisconsin, Madison as lead sponsor. 0 are open to participants now and 8 have results posted.

Phase 1 2Phase 2 9No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Split-Dose R-CHOP for Older Adults With DLBCLActive, not recruitingNCT03943901Phase 2Results posted
• Bendamustine + Obinutuzumab Induction With Obinutuzumab Maintenance in Untreated Mantle Cell LymphomaTerminatedNCT03311126Phase 2Results posted
• TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed LymphomaCompletedNCT02652468Not applicableResults posted
• Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLLCompletedNCT01754857Phase 2Results posted
• Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin LymphomaCompletedNCT01281917Phase 2Results posted
• Ibritumomab Tiuxetan (Zevalin)+ Rituximab MaintenanceTerminatedNCT00582166Phase 2Results posted
• Phase 2 Hyper-CVAD/Rituximab for Untreated Mantle Cell LymphomaCompletedNCT00581854Phase 2Results posted
• Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell LymphomaCompletedNCT00581776Phase 2Results posted
• Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant RecoveryCompletedNCT02955043Not applicable
• Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell TransplantationCompletedNCT02719821Not applicable
• Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)WithdrawnNCT01754870Phase 2
• R-CHOP + GM-CSF for Previously Untreated LCL in ElderlyCompletedNCT00582725Phase 2
• Propofol Versus Propofol-Fentanyl as Sedation For Lumbar Puncture in Children With Acute Leukemia/LymphomaCompletedNCT00214370Not applicable
• Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or LymphomaCompletedNCT00049712Phase 1
• Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerCompletedNCT00036790Phase 1